| Name | Title | Contact Details |
|---|
Walsh, Gregory is a Baltimore, MD-based company in the Business Services sector.
EMA was founded in 1957 as the Secondary School Admission Test Board (SSATB). Changing our name in 2016 was the catalyst of our brand evolution. As the Enrollment Management Association, our name rightfully emphasizes the importance of sustainable enrollment strategies. We are the leading resource dedicated to helping independent school leaders with their enrollment needs. Most know us for pioneering the gold-standard SSAT, administered to 50,000 potential students each year. We have since evolved beyond traditional testing services, offering timely data, insights, and digital solutions to help sustain the independent schools of the future. Weve grown from admissions professionals to a vast network of experts and advocates—developing the industry-standard Character Skills Snapshot, leadership tools like Learning Pass, and first-rate recruitment resources like the Standard Application Online and Student Prospect List. Our vision is to champion transformational education journeys. Our tools and resources provide insights beyond academics so schools can empower students to seamlessly navigate their unique paths to success. Our mission is to provide unparalleled leadership and service in meeting the admission assessment and enrollment needs of schools, students, and families. Together, lets champion transformational education journeys!
A network of 25 free public high schools and middle schools serving 13,000 families in the Los Angeles area, Alliance is one of the most successful charter school networks in nation, as recognized by US News & World Report, Newsweek, the U.S. Departmen...
J. Fletcher Creamer is a Newark, NJ-based company in the Business Services sector.
Caris Life Sciences® (Caris) is the leading next-generation TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced artificial intelligence (AI) and machine learning algorithms, Caris has created the large-scale, clinico-genomic database and computing capability needed to analyze and unravel the molecular complexity of disease. This convergence of sequencing power, big data and AI technologies provides an unmatched platform to deliver the next-generation of precision medicine tools for early detection, diagnosis, monitoring, therapy selection and drug development. Headquartered in Irving, Texas, Caris has offices in Phoenix, New York, Tokyo, Japan and Basel, Switzerland. Caris or its distributor partners provide services in the U.S., Europe, Asia and other international markets.